233 related articles for article (PubMed ID: 19719396)
1. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
[TBL] [Abstract][Full Text] [Related]
3. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
[TBL] [Abstract][Full Text] [Related]
5. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant.
Takatsuka S; Morita T; Koguchi A; Horikiri Y; Yamahara H; Yoshino H
Int J Pharm; 2006 Jun; 316(1-2):124-30. PubMed ID: 16600541
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System.
Onishi H; Tokuyasu A
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649146
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
10. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
[TBL] [Abstract][Full Text] [Related]
11. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
[TBL] [Abstract][Full Text] [Related]
12. Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.
Sun L; Le Z; He S; Liu J; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
Mol Pharm; 2020 Mar; 17(3):757-768. PubMed ID: 32011888
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
du Plessis LH; Lubbe J; Strauss T; Kotzé AF
Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.
Baginski L; Gobbo OL; Tewes F; Salomon JJ; Healy AM; Bakowsky U; Ehrhardt C
Pharm Res; 2012 Jun; 29(6):1425-34. PubMed ID: 22322897
[TBL] [Abstract][Full Text] [Related]
16. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Song KH; Chung SJ; Shim CK
J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
[TBL] [Abstract][Full Text] [Related]
17. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.
Lee YH; Perry BA; Labruno S; Lee HS; Stern W; Falzone LM; Sinko PJ
Pharm Res; 1999 Aug; 16(8):1233-9. PubMed ID: 10468025
[TBL] [Abstract][Full Text] [Related]
18. PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights.
Ryan SM; Frías JM; Wang X; Sayers CT; Haddleton DM; Brayden DJ
J Control Release; 2011 Jan; 149(2):126-32. PubMed ID: 20946924
[TBL] [Abstract][Full Text] [Related]
19. Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.
Youn YS; Kwon MJ; Na DH; Chae SY; Lee S; Lee KC
J Control Release; 2008 Jan; 125(1):68-75. PubMed ID: 18023905
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
Aguirre TA; Rosa M; Coulter IS; Brayden DJ
Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]